AstraZeneca PLC Ordinary Shares · Operating Cash Flow (Statement)

Latest reported$13.81Bperiod endingJun 30, 2026

AZN Cash from Operations ($806.30M → $13.81B)

Annual operating cash flow (statement)

High-resolution chart · PNG

AZN operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	14,575,000,000
Dec 31, 2024	11,861,000,000
Dec 31, 2023	10,345,000,000
Dec 31, 2022	9,808,000,000
Dec 31, 2021	5,963,000,000
Dec 31, 2020	4,799,000,000
Dec 31, 2019	2,969,000,000
Dec 31, 2018	2,618,000,000
Dec 31, 2017	3,578,000,000
Dec 31, 2016	4,145,000,000
Dec 31, 2015	3,324,000,000
Dec 31, 2014	7,058,000,000
Dec 31, 2013	7,400,000,000
Dec 31, 2012	6,948,000,000
Dec 31, 2011	7,821,000,000
Dec 31, 2010	10,680,000,000
Dec 31, 2009	11,739,000,000
Dec 31, 2008	8,742,000,000
Dec 31, 2007	7,510,000,000
Dec 31, 2006	7,693,000,000
Dec 31, 2005	6,743,000,000
Dec 31, 2004	4,873,000,000
Dec 31, 2003	3,416,000,000
Dec 31, 2002	4,833,000,000
Dec 31, 2001	2,706,514,973
Dec 31, 2000	2,336,001,911
Dec 31, 1999	908,552,801
Dec 31, 1998	879,741,057
Dec 31, 1997	747,206,242
Dec 31, 1996	787,752,166
Dec 31, 1995	585,635,700
Dec 31, 1994	625,361,537
Dec 31, 1993	705,579,551
Dec 31, 1992	206,270,000
Dec 31, 1991	505,220,613
Dec 31, 1990	806,296,053